concept

NEURODEGENERATIVE DISEASES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURODEGENERATIVE DISEASES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4620Connections

1Hypotheses

2Analyses

50Outgoing

50Incoming

0Experiments

2Debates

Summary

NEURODEGENERATIVE DISEASES is a concept in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 2536 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of NEURODEGENERATIVE DISEASES

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

💡 Concept Info

Name	NEURODEGENERATIVE DISEASES
Key Genes/Proteins	6-OHDA, AADC, ABCA1, ABCA7, ABCD3, ABCG2
Related Diseases	Aging
Related Pathways	Adaptive Immunity

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| AUTOPHAGY["AUTOPHAGY"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Autophagy["Autophagy"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Apoptosis["Apoptosis"]
        APOPTOSIS["APOPTOSIS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        PARKINSON_S_DISEASE_2["PARKINSON'S DISEASE"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    subgraph Therapeutic["Therapeutic"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| ALS["ALS"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| Als["Als"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        TAU["TAU"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    subgraph Pathology["Pathology"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"contributes to"| Alzheimer["Alzheimer"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"associated with"| AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"]
        PARKINSON_S_DISEASE_1["PARKINSON'S DISEASE"] -->|"associated with"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    style NEURODEGENERATIVE_DISEASES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATIVE_DISORDERS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AMYOTROPHIC_LATERAL_SCLEROSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2418)

Target	Relation	Type	Str
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
Neurodegeneration	regulates	disease	1.00
INFLAMMATION	therapeutic_target	gene	1.00
Aging	associated_with	disease	1.00
Inflammation	therapeutic_target	disease	1.00
INFLAMMATION	associated_with	gene	1.00
Alzheimer	regulates	disease	1.00
Aging	activates	disease	1.00
Als	regulates	disease	1.00
Cancer	associated_with	disease	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
AGING	associated_with	gene	1.00
Neuroinflammation	regulates	disease	1.00
AMYLOID	therapeutic_target	gene	1.00
Parkinson	associated_with	disease	1.00
Apoptosis	therapeutic_target	pathway	1.00
AMYLOID	associated_with	gene	1.00
Huntington	associated_with	disease	1.00
STROKE	associated_with	gene	1.00
AUTOPHAGY	associated_with	gene	1.00
Als	activates	disease	1.00
Dementia	associated_with	disease	1.00
Neurodegeneration	causes	disease	1.00
Cancer	therapeutic_target	disease	1.00
NRF2	activates	gene	1.00
Mtor	therapeutic_target	pathway	1.00
Senescence	associated_with	disease	1.00
NEUROINFLAMMATION	regulates	gene	1.00
Oxidative Stress	regulates	pathway	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
INFLAMMATION	causes	gene	1.00
Neurodegeneration	associated_with	disease	1.00
Parkinson	expressed_in	disease	1.00
Autophagy	associated_with	pathway	1.00
Tumor	activates	disease	1.00
Alzheimer	expressed_in	disease	1.00
Alzheimer	associated_with	disease	1.00
Aging	therapeutic_target	disease	1.00
Aging	regulates	disease	1.00
AGING	regulates	gene	1.00
Parkinson	regulates	disease	1.00
AGING	therapeutic_target	gene	1.00
NEURODEGENERATIVE DISORDERS	activates	gene	1.00
Aging	biomarker_for	disease	1.00
ALZHEIMER'S DISEASE	expressed_in	gene	1.00
Stem Cell	therapeutic_target	pathway	1.00
Tumor	therapeutic_target	disease	1.00
Inflammation	causes	disease	1.00
Inflammation	regulates	disease	1.00

Incoming (2202)

Source	Relation	Type	Str
PARKINSON	causes	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
HUNTINGTON	activates	gene	1.00
NEURODEGENERATION	associated_with	gene	1.00
APOPTOSIS	regulates	gene	1.00
ALZHEIMER	regulates	gene	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
CANCER	associated_with	gene	1.00
NEURODEGENERATION	activates	gene	1.00
ALZHEIMER	expressed_in	gene	1.00
CYTOKINES	activates	gene	1.00
AMPK	activates	gene	1.00
HUNTINGTON	targets	gene	1.00
PARKINSON'S DISEASE	causes	gene	1.00
ALZHEIMER	associated_with	gene	1.00
PARKINSON	activates	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
NF-ΚB	activates	gene	1.00
OXIDATIVE STRESS	regulates	gene	1.00
NEURODEGENERATION	causes	gene	1.00
PARKINSON'S DISEASE	regulates	gene	1.00
ALZHEIMER	causes	gene	1.00
AUTOPHAGY	activates	gene	1.00
NEURODEGENERATION	treats	gene	1.00
ALZHEIMER	treats	gene	1.00
PARKINSON	regulates	gene	1.00
PARKINSON'S DISEASE	activates	gene	1.00
NEUROTOXICITY	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
APOPTOSIS	activates	gene	1.00
APOPTOSIS	therapeutic_target	gene	1.00
TAU	therapeutic_target	gene	1.00
PARKINSON'S DISEASE	associated_with	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
OXIDATIVE STRESS	therapeutic_target	gene	1.00
NEURODEGENERATION	targets	gene	1.00
HUNTINGTON	associated_with	gene	1.00
PARKINSON	associated_with	gene	1.00
AUTOPHAGY	associated_with	gene	1.00
ALZHEIMER	inhibits	gene	1.00
BDNF	activates	gene	1.00
ROS	activates	gene	1.00
NEURODEGENERATION	biomarker_for	gene	1.00
TAU	activates	gene	1.00
NEUROTOXICITY	therapeutic_target	gene	1.00
TNF	activates	gene	1.00
TAU	associated_with	gene	1.00
SIRT1	activates	gene	1.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
microglial priming across neurodegenerative diseases should	0.577	neurodegeneration	Microglial Priming as Upstream Causal No

Mentioning Analyses (2)

Scientific analyses that reference this entity

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 0 hypotheses

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

What are the mechanisms underlying autophagy-lysosome pathway convergence across

closed · Rounds: 5 · Score: 0.95 · 2026-04-01

What are the mechanisms underlying sleep disruption as cause and consequence of

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning NEURODEGENERATIVE DISEASES in their description or question text

No additional research found